Thursday, July 23, 2026 | 9am BST (UK) : De-Risk Automated Liquid Handling with Low Volume Verification (Broadcast 2)

X

Researchers Identify Multi-Action Drug Candidate For Type 2 Diabetes And Bone Disease

Posted on: in News | Life Science News | Pharma News
By:

Related Vitals

FDA Proposes Drug Manufacturing Registration Rule
FDA drug manufacturing registration rule
News

Ris-Rez Hits Phase III Survival Endpoint in Small-Cell Lung Cancer
Ris-Rez works by using an antibody to recognize B7-H3 on cancer cells and help deliver a cancer-killing drug payload inside the cell.
News

FDA Approves Trutakna (Atacicept) for Adults with IgA Nephropathy
Trutakna (atacicept) is given as a once-weekly under-the-skin injection, and patients can self-administer it at home using an autoinjector. Photo courtesy of Vera Therapeutics.
News

Clinical-Stage Biotech Kardigan Raises $460 Million in Nasdaq IPO
Kardigan is developing targeted therapies for genetic heart muscle disease, aortic valve narrowing and blood pressure control after acute severe hypertension.
News

FDA Approves Tregzi: A New Way to Reduce Complications After Blood Cancer Transplants
Tregzi, a donor-derived cell therapy is used as part of matched-donor stem cell transplantation for adults with blood cancers. Photo courtesy of Orca Bio.
News

Related Webinars

September 08, 2026

Challenges and Opportunities in Real-Time Clinical Trials
Hero - Desktop
August 24, 2026

Detect Pharmacy Copay Misuse Before It Erodes GTN
Hero - Desktop
September 03, 2026

Unlocking High-Quality NGS Data from Challenging Clinical Samples
Hero - Desktop
September 03, 2026

From Data Burden to Breakthrough Engine: The Expanding Value of Standards
Hero - Desktop
September 01, 2026

Improve Regulatory Compliance for Pipetting and Liquid Handling Workflows
Hero - Desktop